A Study of Efficacy of New Doses of Xolair to Protect From Allergen Challenge in Groups of Asthma Patients Defined by IgE Levels
- Status
- COMPLETED
- Phase
- PHASE4
Clinical Trials Related to Novartis
Related studies linked through entity extraction aliases.
Tolerability of Indacaterol Salts (Maleate, Xinafoate and Acetate) in Comparison to Placebo in Patients With Mild to Moderate Persistent Asthma
- Status
- COMPLETED
- Phase
- PHASE1
Efficacy and Safety of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
Long-term Safety of Rivastigmine Capsule and Patch in Patients With Mild to Moderately-severe Dementia Associated With Parkinson's Disease (PDD)
- Status
- COMPLETED
- Phase
- PHASE3
A 24 Week, Multicenter, Open, Evaluation of the Clinical Effectiveness of the Once-daily 10 cm^2 Rivastigmine Patch Formulation in Patients With Probable Alzheimer's Disease (EXTRA)
- Status
- COMPLETED
- Phase
- PHASE4
Safety and Tolerability of Single and Multiple Doses of VAK694 in Healthy and Atopic Subjects
- Status
- COMPLETED
- Phase
- PHASE1
The Effect of Indacaterol on Exercise Endurance in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Rheumatoid Arthritis With Ongoing Treatment With Methotrexate
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Safety and Tolerability of Vildagliptin Versus Sitagliptin in Patients With Type 2 Diabetes and Severe Renal Insufficiency
- Status
- COMPLETED
- Phase
- PHASE3
Safety, Tolerability, and Efficacy of AEB071 in the Treatment of Uveitis
- Status
- COMPLETED
- Phase
- PHASE2
A Crossover Study to Determine the Effect on Lung Function of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD), Using Tiotropium as an Active Control
- Status
- COMPLETED
- Phase
- PHASE3
Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD)
- Status
- COMPLETED
- Phase
- PHASE3
PTK787/ZK222584 With Bevacizumab in Patients With Refractory and/or Advanced Malignancies
- Status
- COMPLETED
- Phase
- PHASE1
Imatinib and PTK787/ZK222584 in Refractory and/or Advanced Solid Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Avastin (Bevacizumab) and RAD001 (Everolimus) in Advanced Low or Intermediate Grade Neuroendocrine Carcinoma
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Telbivudine in Patients With Chronic Hepatitis B
- Status
- WITHDRAWN
- Phase
- PHASE4
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ACZ885 in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE2
Safety and Tolerability of Indacaterol Maleate/Mometasone Furoate Delivered Via the Twisthaler® Device After 14 Days Treatment in Patients With Mild to Moderate Asthma
- Status
- COMPLETED
- Phase
- PHASE2
A Patient Handling Study of Mometasone Furoate/Formortoral Fumarate (MF/F) Metered Dose Inhaler (MDI) With an Integrated Dose Counter in Adolescent and Adult Subjects With Asthma or Chronic Obstructive Pulmonary Disease (Study P04703AM1)
- Status
- COMPLETED
- Phase
- PHASE3
Evaluation of Meningococcal ACWY Immune Response in Children Aged 40 and 60 Months
- Status
- COMPLETED
- Phase
- PHASE2